Metabolic pathways of N-methanocarbathymidine, a novel antiviral agent, in native and herpes simplex virus type 1 infected Vero cells.

[1]  Mahmoud Huleihel,et al.  Antiviral effect of red microalgal polysaccharides on Herpes simplex and Varicella zoster viruses , 2001, Journal of Applied Phycology.

[2]  F. Candotti,et al.  Pharmacokinetics and organ distribution of N-methanocarbathymidine, a novel thymidine analog, in mice bearing tumors transduced with the herpes simplex thymidine kinase gene , 2002, Cancer Chemotherapy and Pharmacology.

[3]  R. Snoeck.  Antiviral therapy of herpes simplex. , 2000, International journal of antimicrobial agents.

[4]  G. Schulz,et al.  Kinetics and crystal structure of the wild-type and the engineered Y101F mutant of Herpes simplex virus type 1 thymidine kinase interacting with (North)-methanocarba-thymidine. , 2000, Biochemistry.

[5]  H. Simmonite,et al.  The design, synthesis and properties of highly potent and selective inhibitors of herpes simplex virus types 1 and 2 thymidine kinase. , 1998, Antiviral chemistry & chemotherapy.

[6]  A. Moffatt,et al.  Inhibition of virus-encoded thymidine kinase suppresses herpes simplex virus replication in vitro and in vivo. , 1998, Antiviral chemistry & chemotherapy.

[7]  Z. Ram,et al.  Mechanism of ‘bystander effect’ killing in the herpes simplex thymidine kinase gene therapy model of cancer treatment , 1997, Gene Therapy.

[8]  R. Wagner,et al.  Nucleosides with a twist. Can fixed forms of sugar ring pucker influence biological activity in nucleosides and oligonucleotides , 1996 .

[9]  I. Mitchell,et al.  Comparative in-vivo genotoxicity of antiviral nucleoside analogues; penciclovir, acyclovir, ganciclovir and the xanthine analogue, caffeine, in the mouse bone marrow micronucleus assay. , 1996, Mutation research.

[10]  P. Wutzler,et al.  Cytogenetic genotoxicity of antiherpes virostatics in Chinese hamster V79-E cells. I. Purine nucleoside analogues. , 1996, Antiviral research.

[11]  D. Ilsley,et al.  Acyclic guanosine analogs inhibit DNA polymerases alpha, delta, and epsilon with very different potencies and have unique mechanisms of action. , 1995, Biochemistry.

[12]  R. T. Walker,et al.  Comparative cytostatic activity of different antiherpetic drugs against herpes simplex virus thymidine kinase gene-transfected tumor cells. , 1994, Molecular pharmacology.

[13]  R. Blaese,et al.  Effects of IMP dehydrogenase inhibitors on the phosphorylation of ganciclovir in MOLT-4 cells before and after herpes simplex virus thymidine kinase gene transduction. , 1994, Molecular pharmacology.

[14]  R. Warnick,et al.  In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy. , 1993, Human gene therapy.

[15]  G. Gentry.  Viral thymidine kinases and their relatives. , 1992, Pharmacology & therapeutics.

[16]  F. Hamzeh,et al.  Intranuclear accumulation of subgenomic noninfectious human cytomegalovirus DNA in infected cells in the presence of ganciclovir , 1991, Antimicrobial Agents and Chemotherapy.

[17]  J. Tomaszewski,et al.  Cellular pharmacology of cyclopentenyl cytosine in Molt-4 lymphoblasts. , 1991, Cancer research.

[18]  T. Spector,et al.  Herpes simplex virus type 1 DNA polymerase. Mechanism of inhibition by acyclovir triphosphate. , 1989, The Journal of biological chemistry.

[19]  M. D. Topal,et al.  Insertion and extension of acyclic, dideoxy, and ara nucleotides by herpesviridae, human alpha and human beta polymerases. A unique inhibition mechanism for 9-(1,3-dihydroxy-2-propoxymethyl)guanine triphosphate. , 1988, The Journal of biological chemistry.

[20]  E. De Clercq,et al.  Thymidylate synthase is the principal target enzyme for the cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine against murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 or type 2 thymidine kinase gene. , 1987, Molecular pharmacology.

[21]  P. Furman,et al.  Inhibition by ganciclovir of cell growth and DNA synthesis of cells biochemically transformed with herpesvirus genetic information , 1987, Antimicrobial Agents and Chemotherapy.

[22]  E. De Clercq,et al.  Synthesis and antiviral activity of the carbocyclic analogues of (E)-5-(2-halovinyl)-2'-deoxyuridines and (E)-5-(2-halovinyl)-2'-deoxycytidines. , 1985, Journal of medicinal chemistry.

[23]  R. Boehme.  Phosphorylation of the antiviral precursor 9-(1,3-dihydroxy-2-propoxymethyl)guanine monophosphate by guanylate kinase isozymes. , 1984, The Journal of biological chemistry.

[24]  Y. Cheng,et al.  Interaction of herpes simplex virus-induced DNA polymerase with 9-(1,3-dihydroxy-2-propoxymethyl)guanine triphosphate. , 1984, Journal of Biological Chemistry.

[25]  J. D. Karkas,et al.  A comparison of the antiviral agents 2'-nor-2'-deoxyguanosine and acyclovir: uptake and phosphorylation in tissue culture and kinetics of in vitro inhibition of viral and cellular DNA polymerases by their respective triphosphates. , 1983, Biochemical and biophysical research communications.

[26]  Y. Cheng,et al.  Metabolism of 9-(1,3-dihydroxy-2-propoxymethyl)guanine, a new anti-herpes virus compound, in herpes simplex virus-infected cells. , 1983, The Journal of biological chemistry.

[27]  J. D. Karkas,et al.  9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine: a selective inhibitor of herpes group virus replication. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[28]  J. C. Martin,et al.  Anti-herpesvirus activity of the acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl)guanine , 1983, Antimicrobial Agents and Chemotherapy.

[29]  Y. Cheng,et al.  Inhibition of purified human and herpes simplex virus-induced DNA polymerases by 9-(2-hydroxyethoxymethyl)guanine triphosphate. Effects on primer-template function. , 1981, The Journal of biological chemistry.

[30]  H. Schaeffer,et al.  Enzymatic phosphorylation of acyclic nucleoside analogs and correlations with antiherpetic activities. , 1981, Biochemical pharmacology.

[31]  R. Miller,et al.  Phosphorylation of acyclovir (acycloguanosine) monophosphate by GMP kinase. , 1980, The Journal of biological chemistry.

[32]  R. T. Walker,et al.  Comparative efficacy of antiherpes drugs against different strains of herpes simplex virus. , 1980, The Journal of infectious diseases.

[33]  W. Prusoff,et al.  Kinetic studies of herpes simplex virus type 1-encoded thymidine and thymidylate kinase, a multifunctional enzyme. , 1979, The Journal of biological chemistry.

[34]  R. Miller,et al.  Thymidine kinase from herpes simplex virus phosphorylates the new antiviral compound, 9-(2-hydroxyethoxymethyl)guanine. , 1978, The Journal of biological chemistry.

[35]  H. Schaeffer,et al.  Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine. , 1977, Proceedings of the National Academy of Sciences of the United States of America.